Search Results 1361-1370 of 19167 for Neutrophil

1. The ExTINGUISH Trial Of Inebilizumab In NMDAR Encephalitis (ExTINGUISH) - Mayo Clinic

   Absolute neutrophil count < 1200 cells/μL;; CD4 T lymphocyte count < 300 cells/µL. Receipt of the following at any time prior to randomization: Alemtuzumab ...

2. A Study to Evaluate Adjuvant Ado-Trastuzumab Emtansine (T-DM1) in HER2 Positive Breast Cancer - Mayo Clinic

   Absolute neutrophil count (ANC) ≥1500/mm3;; Platelet count ≥100,000/mm3;; Hemoglobin >9.0 g/dL;; Total bilirubin ≤1.5 x upper limit of normal (ULN). If ...

3. Phase 2 Study with TTI-622 and TTI-621 in Relapsed Diffuse Large B-Cell Lymphoma (DLBCL) - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 500/mm^3; growth factor support allowed in case of bone marrow involvement;; Absolute lymphocyte count ≥200/mm^3 ...

4. A Study to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors - Mayo Clinic

   Absolute Neutrophil count (ANC) ≥1.5 x10^9 /L (without granulocute coloty-stimulating support);; Absolute Lymphocyte count (ALC) ≥ 0.5 x 10^9 /L ...

5. A Study to Evaluate Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia - Mayo Clinic

   Absolute Neutrophil Count (ANC) ≥ 1,000/mm^3 except if due to bone marrow involvement. Platelet Count (untransfused) ≥ 30,000/mm^3. Calc. Creatinine ...

6. Study of the Safety, Pharmacokinetics and Efficacy of EDO-S101, in Patients With Advanced Solid Tumors - Mayo Clinic

   Neutrophils ≥1,500 μL. Platelets ≥100,000 μL. Aspartate aminotransferase/alanine aminotransferase (AST/ALT) ≤ 3 upper limit of normal (ULN). In cases ...

7. A Study to Test the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer - Mayo Clinic

   Absolute neutrophils ≥ 1,500/mcL. Platelets ≥ 100,000/mcL. Hemoglobin ≥ 9 g/dL. Total bilirubin ≤ 1.5 x institutional upper limit of normal (ULN); ...

8. Monoclonal Proteins by Blood Spot and Saliva - Mayo Clinic

   The purpose of this study is to assess the feasibility and develop procedures for detecting monoclonal proteins via finger pick blood spots and saliva. Data ...

9. A Study Of Patients Treated For Chronic Granulomatous Disease Since 1995 - Mayo Clinic

   Participation eligibility · CGD Patients will be defined by both Defective Neutrophil NADPH Oxidase Function and by clinical history consistent with CGD ...

10. Phase 2b Study of Investigational Products in Participants with Interstitial Lung Disease Secondary to Systemic Sclerosis - Mayo Clinic

    Neutrophil blood count < 1500/µL;; Prolongation of prothrombin time and partial thromboplastin time > 1.5 × ULN, or international normalized ratio > 2; or ...